ACPE Accredited** Pharm So Hard Ambulatory Care Podcast Episodes

0% Complete

0/0 Steps

Women’s Health

Oral Contraception Overview

1 Quiz
- Assessment Questions: Women’s Health Series – Oral Contraception
Empowering Access: The Role of Pharmacists in Prescribing Hormonal Contraception

1 Quiz
- Assessment Questions: The Role of Pharmacists in Prescribing Hormonal Contraception
Emergency Contraception: What You Need to Know

1 Quiz
- Assessment Questions: Emergency Contraception: What You Need to Know
GLP-1 Agonists

GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity

1 Quiz
- Assessment Questions: GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity
Diving Deep: The Literature on GLP-1 Agonists

1 Quiz
- Assessment Questions: Diving Deep: The Literature on GLP-1 Agonists
The Great Debate: Unpacking the Controversy of GLP-1 Agonists

1 Quiz
- Assessment Questions: The Great Debate: Unpacking the Controversy of GLP-1 Agonists

Participants 407

Allison Clemens
April
ababaabhay
achoi2392
adhoward1

Quiz 5 of 6

← Previous Next→

Assessment Questions: Diving Deep: The Literature on GLP-1 Agonists

ACPE Accredited** Pharm So Hard Ambulatory Care Podcast Episodes Diving Deep: The Literature on GLP-1 Agonists Assessment Questions: Diving Deep: The Literature on GLP-1 Agonists

Time limit: 0

Quiz Summary

0 of 10 Questions completed

Questions:

Information

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 10 Questions answered correctly

Your time:

Time has elapsed

You have reached 0 of 0 point(s), (0)

Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)

Categories

Not categorized 0%

Current
Review
Answered
Correct
Incorrect

Question 1 of 10

1. Question
What was the primary focus of the Surmount 1 trial?
- A) Evaluating the effectiveness of semaglutide in reducing cardiovascular events
- B) Assessing tirzepatide’s impact on weight loss in patients without diabetes
- C) Comparing GLP-1 receptor agonists to SGLT2 inhibitors for diabetes control
- D) Investigating the role of GLP-1s in preventing Alzheimer’s disease
Correct

Incorrect
Question 2 of 10

2. Question
What was a major limitation of the Surmount 1 trial?
- A) It only included patients with type 2 diabetes
- B) The study population may have had greater commitment to weight loss than the general population
- C) It used a crossover design rather than a placebo comparison
- D) The trial lasted only 4 weeks
Correct

Incorrect
Question 3 of 10

3. Question
What type of study design was used in the trial assessing the gastrointestinal side effects of GLP-1 receptor agonists?
- A) Randomized controlled trial (RCT)
- B) Meta-analysis
- C) Observational cohort study
- D) Case-control study
Correct

Incorrect
Question 4 of 10

4. Question
What is a key limitation of the gastrointestinal side effects study discussed in the episode?
- A) It only included patients on semaglutide
- B) It did not account for pre-existing gastrointestinal conditions
- C) It lasted less than a week
- D) It only assessed hospitalized patients
Correct

Incorrect
Question 5 of 10

5. Question
What was the primary finding of the SELECT trial?
- A) Semaglutide reduced cardiovascular events in patients with obesity and no diabetes
- B) Tirzepatide improved insulin sensitivity in prediabetic patients
- C) GLP-1 receptor agonists were less effective than SGLT2 inhibitors for weight loss
- D) Bupropion/naltrexone was superior to GLP-1s for long-term weight management
Correct

Incorrect
Question 6 of 10

6. Question
What was the number needed to treat (NNT) in the SELECT trial?
- A) 10
- B) 67
- C) 150
- D) 500
Correct

Incorrect
Question 7 of 10

7. Question
What is the mechanism of action of Retatrutide, the triple hormone receptor agonist?
- A) GLP-1 and SGLT2 inhibition
- B) GLP-1, GIP, and glucagon receptor activation
- C) Increased insulin sensitivity through leptin signaling
- D) Dopamine and norepinephrine modulation
Correct

Incorrect
Question 8 of 10

8. Question
What was the average weight loss achieved in the phase 2 trial of Retatrutide?
- A) 15 pounds
- B) 25 pounds
- C) 40 pounds
- D) 58 pounds
Correct

Incorrect
Question 9 of 10

9. Question
What percentage of patients with prediabetes in the Retatrutide phase 2 trial returned to normal glycemic levels?
- A) 30%
- B) 50%
- C) 72%
- D) 90%
Correct

Incorrect
Question 10 of 10

10. Question
What was a key reason the SELECT trial did not apply to all patients with obesity?
- A) It only included patients with diabetes
- B) It focused solely on patients with existing cardiovascular disease
- C) It excluded women
- D) It did not compare semaglutide to other weight loss medications
Correct

Incorrect

ACPE Accredited** Pharm So Hard Ambulatory Care Podcast Episodes

Women’s Health

Participants 407

Assessment Questions: Diving Deep: The Literature on GLP-1 Agonists

Quiz Summary

Information

Results

Results

Categories

1. Question

2. Question

3. Question

4. Question

5. Question

6. Question

7. Question

8. Question

9. Question

10. Question